Loading...
News & Insights2020-02-18T15:42:30+00:00

Digital Pharma East

Events|

Are you attending Digital Pharma East this year? Whether you’re virtual or in-person, don’t miss Precision’s Jon Bambalas chairing the Data and Analytics Track, Thursday 9/30 from 9:30am-12:50pm ET, and speaking as a panelist for the presentation: Accelerate the Value of Data: Explore Different Models for Collecting and Operationalizing Data starting at 12:10pm ET.

(more…)

Impact of NextGen Access Decision Makers on Health Care Services and Therapies

Thought Leadership|

In the midst of the pandemic uncertainties, organizations are continuing their quest for value-based care. Precision’s Elizabeth Oyekan and Dominic Galante discuss who will be the next generation access decision makers to successfully take the Triple Aim premise of value-based care, couple it with lessons learned from the pandemic, scale it up, and sustain success over time to make a palpable difference in the US healthcare system.
(more…)

On-Demand Webinar: How to speed up patient access to innovation: Strategies to convert early European regulatory approval into optimal reimbursement

Events|

In Europe, Conditional Marketing Authorisation (CMA) offers an earlier regulatory nod from the European Medicines Agency (EMA) with lower data requirements than full approval, and with it, the opportunity for gaining earlier patient access. But Health Technology Assessment (HTA) bodies have scrutinized subsequent national-level evidence submissions and have often awarded sub-optimal reimbursement outcomes. This results in inequalities in patient access and impacts the incentives for manufacturers to continue to innovate. So what to do?

(more…)

Webinar: Pricing Strategies for Advanced Therapies

Events|

There is no doubt that the advanced therapies sector is growing at an exponential rate. According to a recently published 2021 Report by ARM (Alliance for Regenerative Medicine), the sector has raised $14.1B in financing in the first half of 2021 which is already 71% of what was raised in all of 2020. In addition, there are over 2,600 advance therapy clinical trials being conducted with 264 of those trails being Phase 3 trials and another 1,500 being Phase 2 trials.

(more…)

Load More Posts